Related Experiment Video
Updated: Jun 22, 2025
13:47
Development of Cell-type specific anti-HIV gp120 aptamers for siRNA delivery
Published on: June 23, 2011
19.6K
Scyllatoxin-based peptide design for E. coli expression and HIV gp120 binding.
Salsabilla Izzah Nurheibah1, Nilofar Danishmalik Sayyed2, Alexander V Batyanovskii3
1Department of Proteome Structural Biology, KRIBB School of Bioscience, Korea University of Science and Technology (UST), Daejeon, 34113, Republic of Korea; Disease Target Structure Research Center, KRIBB, Daejeon, 31441, Republic of Korea.
Biochemical and Biophysical Research Communications
|June 28, 2024
Summary
Researchers developed a cost-effective, microbial method to produce HIV-1 gp120 binding peptides. This scalable approach enhances antiviral peptide production for potential HIV therapies.
Area of Science:
- Biochemistry
- Molecular Biology
- Virology
Background:
- Targeting the hydrophobic Phe43 pocket of HIV envelope glycoprotein gp120 is crucial for antiviral strategies.
- Previous CD4 mimetic peptides showed binding and neutralization but relied on chemical synthesis or non-canonical amino acids.
Purpose of the Study:
- To develop a scalable microbial expression system for an enhanced scyllatoxin-based peptide targeting HIV gp120.
- To optimize the peptide using natural amino acids and reduced disulfide bonds for improved production and efficacy.
Main Methods:
- Engineered a scyllatoxin-based peptide for microbial expression in E. coli using natural amino acids.
- Modified the peptide by altering C-terminal residues and reducing disulfide bonds from three to two.
- Utilized circular dichroism for structural confirmation and fluorescence polarization assays for binding analysis.
- Performed molecular dynamics simulations to support binding interactions.
Main Results:
- Successfully expressed the optimized peptide in E. coli.
- Confirmed proper secondary structure formation via circular dichroism.
- Demonstrated specific, concentration-dependent binding of the peptide to HIV gp120 using fluorescence polarization.
- Molecular dynamics simulations corroborated the binding interactions.
Conclusions:
- Scalable microbial production of effective antiviral peptides targeting HIV gp120 is feasible.
- The optimized peptide shows potential for pharmaceutical development in HIV treatment.
- This approach offers a cost-effective and efficient alternative to traditional peptide synthesis.
